4ews

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
<StructureSection load='4ews' size='340' side='right'caption='[[4ews]], [[Resolution|resolution]] 2.59&Aring;' scene=''>
<StructureSection load='4ews' size='340' side='right'caption='[[4ews]], [[Resolution|resolution]] 2.59&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4ews]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EWS OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4EWS FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4ews]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EWS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4EWS FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0RP:ETHYL+(2R,4S)-4-{[3,5-BIS(TRIFLUOROMETHYL)BENZYL](METHOXYCARBONYL)AMINO}-2-ETHYL-6-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE'>0RP</scene>, <scene name='pdbligand=2OB:CHOLESTERYL+OLEATE'>2OB</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DLP:1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>DLP</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0RP:ETHYL+(2R,4S)-4-{[3,5-BIS(TRIFLUOROMETHYL)BENZYL](METHOXYCARBONYL)AMINO}-2-ETHYL-6-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE'>0RP</scene>, <scene name='pdbligand=2OB:CHOLESTERYL+OLEATE'>2OB</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DLP:1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>DLP</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2obd|2obd]]</td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ews FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ews OCA], [https://pdbe.org/4ews PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ews RCSB], [https://www.ebi.ac.uk/pdbsum/4ews PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ews ProSAT]</span></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ews FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ews OCA], [http://pdbe.org/4ews PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4ews RCSB], [http://www.ebi.ac.uk/pdbsum/4ews PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4ews ProSAT]</span></td></tr>
+
</table>
</table>
== Disease ==
== Disease ==
-
[[http://www.uniprot.org/uniprot/CETP_HUMAN CETP_HUMAN]] Defects in CETP are the cause of hyperalphalipoproteinemia type 1 (HALP1) [MIM:[http://omim.org/entry/143470 143470]]. Affected individuals show high levels of alpha-lipoprotein (high density lipoprotein/HDL).<ref>PMID:2215607</ref> <ref>PMID:8408659</ref> <ref>PMID:12091484</ref>
+
[https://www.uniprot.org/uniprot/CETP_HUMAN CETP_HUMAN] Defects in CETP are the cause of hyperalphalipoproteinemia type 1 (HALP1) [MIM:[https://omim.org/entry/143470 143470]. Affected individuals show high levels of alpha-lipoprotein (high density lipoprotein/HDL).<ref>PMID:2215607</ref> <ref>PMID:8408659</ref> <ref>PMID:12091484</ref>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/CETP_HUMAN CETP_HUMAN]] Involved in the transfer of insoluble cholesteryl esters in the reverse transport of cholesterol.
+
[https://www.uniprot.org/uniprot/CETP_HUMAN CETP_HUMAN] Involved in the transfer of insoluble cholesteryl esters in the reverse transport of cholesterol.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 25: Line 24:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Liu, S]]
+
[[Category: Liu S]]
-
[[Category: Qiu, X]]
+
[[Category: Qiu X]]
-
[[Category: Cholestryl ester transfer protein]]
+
-
[[Category: Cholestryl ester transfer protein-inhibitor complex]]
+
-
[[Category: High-density lipoprotein]]
+
-
[[Category: Lipid transport-inhibitor complex]]
+
-
[[Category: Low-density lipoprotein]]
+

Revision as of 04:20, 7 October 2022

Crystal structure of cholesteryl ester transfer protein in complex with inhibitors

PDB ID 4ews

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools